Business

Mass. Movers

Post-acquisition, Cynosure loses $1.3m

Cynosure, which makes laser-and light-based aesthetic treatment systems, unveiled a $25 million stock buyback.
Cynosure, which makes laser-and light-based aesthetic treatment systems, unveiled a $25 million stock buyback.
Advertisement

Cynosure Inc. reported a net loss of $1.3 million, or 6 cents per share, including acquisition costs for Palomar, which it purchased in June. Excluding those costs, earnings per share were 23 cents. Revenue of $60.7 million, while up 64 percent, fell short of the consensus estimate of $61.6 million. It was the first full quarter for the combined company. CEO Michael Davin said the acquisition remains on track to achieve $8 million to $10 million in cost synergies.